Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa exploratory study of CPT monotherapy in multiple advanced solid tumors
ChiCTR-ONRC-12002086Phase 2Completed
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Dec 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of camptothecin in gastric cancer (GC), colorectal cancer (CRC), pancreatic cancer (PC) and 2 more, sponsored by Fudan University Shanghai Cancer Center. Primary endpoints: objective response rate and adverse events. Started Dec 2009; status: completed.
02
Drugs
camptothecin
03
Conditions
gastric cancer (GC)colorectal cancer (CRC)pancreatic cancer (PC)non-small cell lung cancer (NSCLC)Non-hematologic malignancy
Beyond the preview
Go deeper on ChiCTR-ONRC-12002086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12002086.